Methotrexate Disodium Salt is a synthetic folate antagonist classified as an antimetabolite chemotherapy agent that functions by inhibiting dihydrofolate reductase to block DNA synthesis and cell division.… Read more
Methotrexate Disodium Salt is a synthetic folate antagonist classified as an antimetabolite chemotherapy agent that functions by inhibiting dihydrofolate reductase to block DNA synthesis and cell division. This compound is clinically utilized to manage various malignancies, including leukemia and lymphoma, as well as autoimmune conditions such as rheumatoid arthritis and ectopic pregnancies. Analytical laboratories rely on high-quality reference standards of this drug, alongside its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, to ensure precise quality control and rigorous method validation. By utilizing these materials, researchers can perform accurate impurity profiling and quantitative analysis throughout the pharmaceutical development process. Accessing these specialized analytical tools is essential for maintaining compliance with regulatory standards and ensuring the consistency, safety, and efficacy of pharmaceutical formulations containing this active ingredient.